-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MMMSiAEP9vTdwgIlSRicpXCK1vHkgwdxSFqstNHJYN9yIZfVVZ+H9dFRo2hpmlFk JShwl2a5JEisTSegKzmy2g== 0001209191-09-049081.txt : 20091019 0001209191-09-049081.hdr.sgml : 20091019 20091019171006 ACCESSION NUMBER: 0001209191-09-049081 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091015 FILED AS OF DATE: 20091019 DATE AS OF CHANGE: 20091019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WYETH CENTRAL INDEX KEY: 0000005187 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 132526821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9736605000 MAIL ADDRESS: STREET 1: 5 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN HOME PRODUCTS CORP DATE OF NAME CHANGE: 20020308 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN HOME PRODUCTS CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COST TIMOTHY CENTRAL INDEX KEY: 0001174702 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01225 FILM NUMBER: 091126441 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2009-10-15 1 0000005187 WYETH WYE 0001174702 COST TIMOTHY 5 GIRALDA FARMS MADISON NJ 07940 0 1 0 0 Sr. VP- Corporate Affairs Common Stock 2009-10-15 4 D 0 5883.1876 D 0 D Employee Stock Option 41.88 2009-10-15 4 D 0 27000 7.70 D Common Stock 27000 0 D Employee Stock Option 44.56 2009-10-15 4 D 0 30000 5.02 D Common Stock 30000 0 D Pursuant to the Agreement and Plan of Merger by and among Wyeth, Pfizer Inc. and Wagner Acquisition Corp. dated as of January 25, 2009 (as amended, the "Merger Agreement"), each of these shares was cancelled at the effective time of the merger and converted into the right to receive $33.00 in cash and 0.985 of a share of Pfizer Inc. common stock, less any applicable tax withholding. Pursuant to the Merger Agreement, each outstanding and unexercised option, whether vested or unvested, was cancelled at the effective time of the merger in exchange for cash equal to the product of (a) the number of shares underlying such option and (b) the excess, if any, of the per share value of the merger consideration of $49.58 over the per share exercise price of the option, less any applicable tax withholding. Tara J. Gabbai, Attorney-in-Fact for Timothy P. Cost 2009-10-19 -----END PRIVACY-ENHANCED MESSAGE-----